A key step forward for Novo Nordisk’s GLP-1 pill
Novo Nordisk flags flutter outside their office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, July 14, 2025.…
Novo Nordisk to buy Akero Therapeutics
A view of the logo of Novo Nordisk at the company’s office in Bagsvaerd, on the outskirts of…
Johnson & Johnson ordered to pay $966 million after jury finds company liable in talc cancer case
In this photo illustration, a container of Johnson’s baby powder made by Johnson and Johnson sits on a…
Pfizer’s new obesity bet, Metsera, releases drug data
Thomas Fuller | SOPA Images | Lightrocket | Getty Images A version of this article first appeared in…
Eli Lilly plans $6.5 billion Texas manufacturing plant for obesity pill
A rendering of Eli Lilly’s manufacturing facility in Houston, Texas. Courtesy: Eli Lilly Eli Lilly on Tuesday said…
RFK Jr.’s vaccine panel postpones vote on hepatitis B shot for babies
Health and Human Services Secretary Robert F. Kennedy Jr.’s hand-picked vaccine panel on Friday postponed a vote on…
Eli Lilly to build $5 billion Virginia manufacturing facility
Eli Lilly Biotechnology Center is shown in San Diego, California, March 1, 2023. Mike Blake | Reuters Eli…
Novo Nordisk flags Cagrilintide promise in hunt for next obesity drug
The logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy…
Novo Nordisk’s Martin Holst Lange previews obesity pill
A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news…
Eli Lilly’s Daniel Skovronsky talks obesity pill data
The Eli Lilly headquarters in Indianapolis, Indiana, on Aug. 15, 2024. AJ Mast | Bloomberg | Getty Images…
Rocket Pharma’s shares soar after US FDA lets gene therapy trial resume
Rafael Henrique | SOPA Images | AP The U.S. health regulator has allowed a study of Rocket Pharmaceuticals’…